Multifunctional nanoparticles for use in theranostic applications

Drug Delivery and Translational Research
James T Cole, Nolan B Holland

Abstract

Theranostics is a promising field that combines therapeutics and diagnostics into single multifunctional formulations. This field is driven by advancements in nanoparticle systems capable of providing the necessary functionalities. By utilizing these powerful nanomedicines, the concept of personalized medicine can be realized by tailoring treatment strategies to the individual. This review gives a brief overview of the components of a theranostic system and the challenges that designing truly multifunctional nanoparticles present. Considerations when choosing a class of nanoparticle include the size, shape, charge, and surface chemistry, while classes of nanoparticles discussed are polymers, liposomes, dendrimers, and polymeric micelles. Targeting to disease states can be achieved either through passive or active targeting which uses specific ligands to target receptors that are overexpressed in tumors and common targeting elements are presented. To image the interactions with disease states, contrast agents are included in the nanoparticle formulation. Imaging options include optical imaging techniques, computed tomography, nuclear based, and magnetic resonance imaging. The interplay between all of these components needs to be...Continue Reading

References

Apr 13, 1995·The New England Journal of Medicine·E K Rowinsky, R C Donehower
Mar 28, 1996·Nature·R Pasqualini, E Ruoslahti
Dec 3, 1999·The International Journal of Biochemistry & Cell Biology·P Ponka, C N Lok
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H MaedaK Hori
Mar 4, 2000·Advanced Drug Delivery Reviews·J Sudimack, R J Lee
Sep 1, 2000·Advanced Drug Delivery Reviews·F NilssonD Neri
Feb 13, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·K S SoppimathW E Rudzinski
Aug 31, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H GelderblomA Sparreboom
Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y Yarden
Dec 1, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S GotoT Kondo
Sep 5, 2002·Nature Reviews. Cancer·Sanjiv Sam Gambhir
Nov 14, 2002·Pharmacological Reviews·Zhong Ming QianKwokping Ho
Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Jun 5, 2003·Nature Medicine·Napoleone FerraraJennifer LeCouter
Aug 16, 2003·Endocrine Reviews·Jean Claude Reubi
Aug 19, 2003·Biomaterials·Ulrich HerselHorst Kessler
Dec 18, 2003·Drug Discovery Today·Sanjeeb K Sahoo, Vinod Labhasetwar
Feb 3, 2004·Journal of Cellular Biochemistry·Arundhati Ghosh, Warren D W Heston
Mar 5, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M E R O'BrienUNKNOWN CAELYX Breast Cancer Study Group
Mar 5, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y MatsumuraK Takahashi
Mar 20, 2004·Science·Theresa M Allen, Pieter R Cullis
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tae-You KimYung-Jue Bang
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Sep 8, 2004·Advanced Drug Delivery Reviews·Lisa Brannon-Peppas, James O Blanchette
Sep 8, 2004·International Journal of Cancer. Journal International Du Cancer·Sanjeeb K SahooVinod Labhasetwar
Oct 20, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sunil A AgnihotriTejraj M Aminabhavi
Oct 29, 2004·Nature Reviews. Cancer·Carl-Henrik HeldinArne Ostman
Feb 22, 2005·Critical Reviews in Therapeutic Drug Carrier Systems·Indu BalaM N V Ravi Kumar
Jun 2, 2005·Nature Materials·Igor L MedintzHedi Mattoussi
Jun 10, 2005·Nano Letters·Omid VeisehMiqin Zhang
Sep 2, 2005·Journal of Pharmaceutical Sciences·Andrew R Hilgenbrink, Philip S Low
Oct 26, 2005·Drug Discovery Today·Francesco M Veronese, Gianfranco Pasut
Feb 3, 2006·The New England Journal of Medicine·Malik E Juweid, Bruce D Cheson
Feb 24, 2006·Biochimica Et Biophysica Acta·Oneel PatelGraham S Baldwin
Apr 28, 2006·Expert Opinion on Drug Delivery·Raymond M Schiffelers, Gert Storm
May 3, 2006·Biomaterials·Arnaud VonarbourgJean-Pierre Benoit
Jun 3, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M R GreenM J Hawkins
Sep 6, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Samah AnabousiCarsten Ehrhardt
Nov 17, 2006·Pharmaceutical Research·V P Torchilin

❮ Previous
Next ❯

Citations

Jan 6, 2016·International Journal of Molecular Sciences·Sergey V GudkovAndrei V Zvyagin
Dec 10, 2015·Frontiers in Pharmacology·Lisa SercombeSusan Hua
Sep 16, 2015·Soft Matter·B Sierra-Martin, A Fernandez-Barbero
Apr 2, 2016·Pharmaceutical Research·M Luísa CorvoAlexandra R Fernandes
Sep 16, 2015·The International Journal of Biochemistry & Cell Biology·Valentina ColapicchioniGiulio Caracciolo
Sep 25, 2016·Trends in Biotechnology·Giulio CaraccioloMorteza Mahmoudi
Oct 6, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Pramod JagtapShalini Gupta
Aug 26, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lingzhou ZhaoJinhua Zhao
Dec 31, 2017·Drug Delivery and Translational Research·Maria Natalia CalienniJorge Montanari
Jan 19, 2018·Nanomedicine·Bandhan ChatterjeeSiddhartha Sankar Ghosh
Aug 8, 2019·Journal of Biomedical Materials Research. Part a·Md AquibBo Wang
Nov 2, 2018·Current Medicinal Chemistry·Anna Rita BiliaMaria Camilla Bergonzi
Aug 3, 2016·European Journal of Nanomedicine·Weifei LuWeibo Cai
Nov 3, 2015·Nanomaterials·Pedro PedrosaPedro V Baptista
Jan 7, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Raquel Mejia-ArizaJurriaan Huskens
Aug 21, 2020·Journal of Drug Targeting·Mohsen GhaferiSeyed Ebrahim Alavi
Jul 7, 2016·Journal of Materials Chemistry. B, Materials for Biology and Medicine·S PalchettiG Caracciolo
Dec 28, 2016·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Xinru YouJun Wu
May 26, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Philip GrossenJörg Huwyler
Nov 9, 2017·Langmuir : the ACS Journal of Surfaces and Colloids·James Nicholas VranishIgor L Medintz
Oct 22, 2019·Molecular Pharmaceutics·Cátia DominguesAna Figueiras

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Advanced Drug Delivery Reviews
Siti M JanibJ Andrew MacKay
Journal of Controlled Release : Official Journal of the Controlled Release Society
Ju Hee RyuIck Chan Kwon
© 2021 Meta ULC. All rights reserved